Predict your next investment

HEALTHCARE | Biotechnology
endocube.fr

See what CB Insights has to offer

Founded Year

2001

Stage

Convertible Note - II | Dead

Total Raised

$5.7M

Last Raised

$360K

About Endocube

Developer of drugable targets and product candidates for the diagnosis and treatment of major chronic inflammatory conditions. The company's core strategy is to study specific endothelial cells, called cuboidals, that line tiny blood vessels in various human inflamed tissues to unlock novel inflammatory pathways and identify target molecules to modulate diseases such as rheumatoid arthritis, Crohn's disease, and allergic inflammatory disorders.

Endocube Headquarter Location

Prologue Biotech Rue Pierre & Marie Curie, BP 28262

Labege, 31682,

France

33 5 61 28 70 70

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.